Search for dissertations about: "26S proteasome"
Showing result 1 - 5 of 14 swedish dissertations containing the words 26S proteasome.
-
1. Investigating the activation and regulation of the proteasome : an essential proteolytic complex
Abstract : The proteasome is a major non-lysosomal proteolytic complex present in eukaryotic cells and has a central role in regulating many protein levels. The complex has been shown to participate in various intracellular pathways including cell cycle regulation or quality control of newly synthesized proteins and many other key pathways. READ MORE
-
2. Links between Aging and Proteostasis Decline in Saccharomyces cerevisiae
Abstract : Proteins are continuously synthesized and degraded to meet the demands of the cell. Hence, a proper balance between synthesis, folding, disaggregation and degradation is of essence to ensure cell survival. Disruption of any part of this proteostasis network may have severe consequences for cellular fitness and longevity. READ MORE
-
3. Nanoscopic adventures : unraveling macromolecular complexes in infectious diseases via integrative structural biology
Abstract : This thesis focuses on understanding the underlying molecular mechanisms of infectious diseases, which claim nearly 9 million lives annually. The research centers on critical analysis of pathogen mechanisms and drug resistance. I have mainly focused on two clades of pathogens: Enterococcus faecalis and microsporidia. E. READ MORE
-
4. Studies of metazoan proteasome function and regulation
Abstract : Biological processes depend upon the structural and functional quality of the molecules that comprise living organisms. The integrity of molecules such as DNA, RNA, proteins, carbohydrates and lipids is crucial and the precise three-dimensional shape and the detailed chemistry of these molecules orchestrate the biochemical processes vital for life. READ MORE
-
5. Identification and characterization of a proteasome deubiquitinase inhibitor
Abstract : The 26S proteasome has emerged as an attractive therapeutic target in the treatment of cancers. Proteasome inhibitors have been shown to selectively kill cancer cells. The FDA approval of bortezomib for the treatment of multiple myeloma and mantle cell lymphoma has clinically validated the 26S proteasome as a therapeutic target in oncology. READ MORE